PHAR Insider Trading
Pharming Group N.V. (PHAR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $668.1M, listed on NASDAQ, employing roughly 407 people, carrying a beta of 0.09 to the broader market. Pharming Group N. Led by Fabrice Chouraqui, public since 2020-12-23.
No insider filings are on record under PHAR's own SEC company ID (CIK 1828316).
Filings Under Another SEC Company ID
1 filing line on file was filed under an SEC company ID (CIK) other than PHAR's (1828316). Such a filing can be a predecessor company's (one that reorganized, redomiciled or converted files under a new CIK), a former holder of the PHAR ticker's, or another company's that PHAR or its insiders report holding; the CIK alone does not say which. It is not counted in the figures above.
| CIK | Lines | Dates | Securities |
|---|---|---|---|
| 1072546 | 1 | May 27, 2004 | Stock Option (right to buy) |
PHAR Institutional Ownership (13F)
As of Jun 30, 2026 (Q2 2026), 18 institutions reported holding 2,243,764 PHAR shares, valued at $4.3M as reported, 0.5% of its market cap (market cap of Jun 26, 2026). That is +5 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 7 opened a position, 3 closed one, 3 added and 6 trimmed.
Top Holders, Q2 2026
| Manager | Shares | Value | Change |
|---|---|---|---|
| MAC Alpha Capital Management, LP | 2,148,144 | $2.9M | New |
| Silverberg Bernstein Capital Management LLC | 41,547 | $577.1K | -3,200 |
| Crossmark Global Holdings, Inc. | 12,463 | $169.0K | New |
| CITADEL ADVISORS LLC | 11,972 | $162.3K | +1,783 |
| MORGAN STANLEY | 11,500 | $159.7K | +11 |
| SmartHarvest Portfolios, LLC | 10,415 | $144.7K | -382 |
| Knoll Capital Management, LLC | 4,091 | $56.8K | +34 |
| Silver Grove Financial Group, Inc. | 1,071 | $14.9K | New |
| Nalls Sherbakoff Group, LLC | 870 | $12.1K | Unchanged |
| Global Retirement Partners, LLC | 456 | $6.3K | No comparable report |
By Quarter
| Quarter | Institutions | Shares | Value |
|---|---|---|---|
| Q2 2026 | 18 | 2,243,764 | $4.3M |
| Q1 2026 | 13 | 85,838 | $1.4M |
| Q4 2025 | 11 | 140,455 | $2.5M |
| Q3 2025 | 9 | 59,130 | $857.3K |
| Q2 2025 | 3 | 58,026 | $620.3K |
| Q1 2025 | 3 | 51,003 | $426.7K |
| Q4 2024 | 5 | 51,101 | $514.3K |
| Q3 2024 | 4 | 44,747 | $369.2K |
| Q2 2024 | 4 | 30,392 | $253.8K |
From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.
Learn how insider trading is reported and how to read the data →